Hans Van der Vliet

Hans Van der Vliet

Company: LAVA Therapeutics

Job title: Chief Scientific Officer


Bispecific Vγ9Vδ2-T Cell Engagers for Immunotherapy of Solid & Hematological Malignancies 9:30 am

Discussing the design and preclinical work to demonstrate efficacy and safety of bispecific engagers directed against Vγ9Vδ2-T cells Highlighting the tri-specific properties of a CD1d-Vδ2 bispecific T cell engager Presentation of early clinical and pharmacodynamics data from phase 1 programsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.